Compatibility of the Abbott IMx homocysteine assay with citrate-anticoagulated plasma and stability of homocysteine in citrated whole blood

Clinical Chemistry

Volumn 47, Issue 9, 2001, Pages 1704-1707

  Palmer Toy, D E ^a   Szczepiorkowski, Z M ^a   Shih, V ^a   Van Cott, E M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; EDETIC ACID; HEMOGLOBIN; HOMOCYSTEINE;

ARTICLE; ASSAY; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; PLASMA VOLUME;

EID: 0034866540     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.9.1704     Document Type: Article

References (15)

1. Hyperhomocysteinemia, atherosclerosis and thrombosis
2. Homocysteine and atherothrombosis
3. Hyperhomocysteinemia and venous thrombosis: A meta-analysis
4. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis?
5. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
6. Hyperhomocysteinemia and deep-vein thrombosis. A case control study
7. Laboratory evaluation of hypercoagulable states
8. Acidic citrate stabilizes blood samples for assay of total homocysteine
9. Stability of blood homocysteine and other thiols: EDTA or acidic citrate?
10. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbot IMx analyzer
11. Effects of anticoagulants in amino acid analysis: Comparisons of heparin, EDTA, and sodium citrate in Vacutalner Tubes for plasma preparation
12. Variations in blood levels of aminoglycosides related to In vitro anticoagulant usage
13. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer
14. Effects of anticoagulants on lipoprotein(a) measurements with four commercial assays
15. Use of different anticoagulants in test tubes for analysis of blood lactate concentrations. Part 2. Implications for the proper handling of blood specimens obtained from critically ill patients